What to watch for as J&J gets ready to split into two separate companies next year
We consider Johnson & Johnson one of our 10 core holdings and will like it even more after the consumer health brand spinoff.
Tekef
0
35
Johnson & Johnson products for sale in New York.
Scott Mlyn | CNBC
Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of the split, Morgan Stanley put out a research note, highlighting some of the debates in the market over the move, which would result in a consumer brands company called Kenvue and a pharma company with the J&J moniker.
